{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:52:51Z","timestamp":1790031171813,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD080474"],"award-info":[{"award-number":["R01 HD080474"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 Al118500"],"award-info":[{"award-number":["R01 Al118500"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI125064"],"award-info":[{"award-number":["R01 AI125064"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068632 (IMPAACT LOC)"],"award-info":[{"award-number":["UM1AI068632 (IMPAACT LOC)"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068616 (IMPAACT SDMC)"],"award-info":[{"award-number":["UM1AI068616 (IMPAACT SDMC)"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106716 (IMPAACT LC)"],"award-info":[{"award-number":["UM1AI106716 (IMPAACT LC)"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11904-018-0412-1","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T23:01:26Z","timestamp":1535583686000},"page":"382-387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["CNS Persistence of HIV-1 in Children: the Untapped Reservoir"],"prefix":"10.1007","volume":"15","author":[{"given":"Ann","family":"Chahroudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Persaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"412_CR1","unstructured":"UNAIDS Global AIDS Update 2016: UNAIDS 2016. Available from: http:\/\/www.unaids.org\/en\/resources\/documents\/2016\/Global-AIDS-update-2016 ."},{"issue":"3","key":"412_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s13365-014-0287-x","volume":"21","author":"SB Joseph","year":"2015","unstructured":"Joseph SB, Arrildt KT, Sturdevant CB, Swanstrom R. HIV-1 target cells in the CNS. J Neuro-Oncol. 2015;21(3):276\u201389. https:\/\/doi.org\/10.1007\/s13365-014-0287-x .","journal-title":"J Neuro-Oncol"},{"issue":"14","key":"412_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1056\/NEJM198810063191401","volume":"319","author":"PA Pizzo","year":"1988","unstructured":"Pizzo PA, Eddy J, Falloon J, Balis FM, Murphy RF, Moss H, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med. 1988;319(14):889\u201396. https:\/\/doi.org\/10.1056\/NEJM198810063191401 .","journal-title":"N Engl J Med"},{"issue":"12","key":"412_CR4","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/cid\/civ687","volume":"61","author":"Gayatri Mirani","year":"2015","unstructured":"Mirani G, Williams PL, Chernoff M, Abzug MJ, Levin MJ, Seage GR 3rd, et al. Changing trends in complications and mortality rates among US youth and young adults with HIV infection in the era of combination antiretroviral therapy. Clin Infect. Dis. 2015;61(12):1850\u201361. https:\/\/doi.org\/10.1093\/cid\/civ687 .","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl","key":"412_CR5","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1002\/ana.410230709","volume":"23","author":"LG Epstein","year":"1988","unstructured":"Epstein LG, Sharer LR, Goudsmit J. Neurological and neuropathological features of human immunodeficiency virus infection in children. Ann Neurol. 1988;23(Suppl):S19\u201323.","journal-title":"Ann Neurol"},{"issue":"14","key":"412_CR6","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1097\/QAD.0b013e32832dc041","volume":"23","author":"K Patel","year":"2009","unstructured":"Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd, et al. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS. 2009;23(14):1893\u2013901. https:\/\/doi.org\/10.1097\/QAD.0b013e32832dc041 .","journal-title":"AIDS"},{"issue":"3","key":"412_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/QAI.0000000000000295","volume":"67","author":"H Brahmbhatt","year":"2014","unstructured":"Brahmbhatt H, Boivin M, Ssempijja V, Kigozi G, Kagaayi J, Serwadda D, et al. Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV. J Acquir Immune Defic Syndr. 2014;67(3):316\u201322. https:\/\/doi.org\/10.1097\/QAI.0000000000000295 .","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"412_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejpn.2007.09.002","volume":"12","author":"S Koekkoek","year":"2008","unstructured":"Koekkoek S, de Sonneville LM, Wolfs TF, Licht R, Geelen SP. Neurocognitive function profile in HIV-infected school-age children. Eur J Paediatr Neurol. 2008;12(4):290\u20137. https:\/\/doi.org\/10.1016\/j.ejpn.2007.09.002 .","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"412_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/INF.0b013e31827fb19d","volume":"32","author":"T Puthanakit","year":"2013","unstructured":"Puthanakit T, Ananworanich J, Vonthanak S, Kosalaraksa P, Hansudewechakul R, van der Lugt J, et al. Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J. 2013;32(5):501\u20138. https:\/\/doi.org\/10.1097\/INF.0b013e31827fb19d .","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"412_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/INF.0b013e318253844b","volume":"31","author":"R Smith","year":"2012","unstructured":"Smith R, Chernoff M, Williams PL, Malee KM, Sirois PA, Kammerer B, et al. Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J. 2012;31(6):592\u20138. https:\/\/doi.org\/10.1097\/INF.0b013e318253844b .","journal-title":"Pediatr Infect Dis J"},{"issue":"3 Pt 1","key":"412_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1542\/peds.112.3.679","volume":"112","author":"MA Tamula","year":"2003","unstructured":"Tamula MA, Wolters PL, Walsek C, Zeichner S, Civitello L. Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease. Pediatrics. 2003;112(3 Pt 1):679\u201384.","journal-title":"Pediatrics"},{"issue":"14","key":"412_CR12","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1097\/QAD.0b013e32832d924f","volume":"23","author":"SM Wood","year":"2009","unstructured":"Wood SM, Shah SS, Steenhoff AP, Rutstein RM. The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV. AIDS. 2009;23(14):1859\u201365. https:\/\/doi.org\/10.1097\/QAD.0b013e32832d924f .","journal-title":"AIDS"},{"issue":"7","key":"412_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/cid\/cir1037","volume":"54","author":"T. D. Ruel","year":"2012","unstructured":"Ruel TD, Boivin MJ, Boal HE, Bangirana P, Charlebois E, Havlir DV, et al. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin. Infect. Dis. 2012;54(7):1001\u20139. https:\/\/doi.org\/10.1093\/cid\/cir1037 .","journal-title":"Clinical Infectious Diseases"},{"issue":"13","key":"412_CR14","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/QAD.0b013e328355d0ce","volume":"26","author":"B Laughton","year":"2012","unstructured":"Laughton B, Cornell M, Grove D, Kidd M, Springer PE, Dobbels E, et al. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS. 2012;26(13):1685\u201390. https:\/\/doi.org\/10.1097\/QAD.0b013e328355d0ce .","journal-title":"AIDS"},{"issue":"3","key":"412_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/QAD.0000000000000528","volume":"29","author":"CS Crowell","year":"2015","unstructured":"Crowell CS, Huo Y, Tassiopoulos K, Malee KM, Yogev R, Hazra R, et al. Early viral suppression improves neurocognitive outcomes in HIV-infected children. AIDS. 2015;29(3):295\u2013304. https:\/\/doi.org\/10.1097\/QAD.0000000000000528 .","journal-title":"AIDS"},{"key":"412_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nicl.2013.10.012","volume":"4","author":"MK Sarma","year":"2014","unstructured":"Sarma MK, Nagarajan R, Keller MA, Kumar R, Nielsen-Saines K, Michalik DE, et al. Regional brain gray and white matter changes in perinatally HIV-infected adolescents. Neuroimage Clin. 2014;4:29\u201334. https:\/\/doi.org\/10.1016\/j.nicl.2013.10.012 .","journal-title":"Neuroimage Clin"},{"issue":"37","key":"412_CR17","doi-asserted-by":"publisher","first-page":"e1417","DOI":"10.1097\/MD.0000000000001417","volume":"94","author":"MM Herting","year":"2015","unstructured":"Herting MM, Uban KA, Williams PL, Gautam P, Huo Y, Malee K, et al. Default mode connectivity in youth with perinatally acquired HIV. Medicine (Baltimore). 2015;94(37):e1417. https:\/\/doi.org\/10.1097\/MD.0000000000001417 .","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"412_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/QAD.0000000000000648","volume":"29","author":"KA Uban","year":"2015","unstructured":"Uban KA, Herting MM, Williams PL, Ajmera T, Gautam P, Huo Y, et al. White matter microstructure among youth with perinatally acquired HIV is associated with disease severity. AIDS. 2015;29(9):1035\u201344. https:\/\/doi.org\/10.1097\/QAD.0000000000000648 .","journal-title":"AIDS"},{"issue":"6","key":"412_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/COH.0000000000000108","volume":"9","author":"LR Gray","year":"2014","unstructured":"Gray LR, Roche M, Flynn JK, Wesselingh SL, Gorry PR, Churchill MJ. Is the central nervous system a reservoir of HIV-1? Curr Opin HIV AIDS. 2014;9(6):552\u20138. https:\/\/doi.org\/10.1097\/COH.0000000000000108 .","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"412_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11912-002-0074-3","volume":"4","author":"TA Kaleita","year":"2002","unstructured":"Kaleita TA. Central nervous system-directed therapy in the treatment of childhood acute lymphoblastic leukemia and studies of neurobehavioral outcome: Children\u2019s Cancer Group trials. Curr Oncol Rep. 2002;4(2):131\u201341.","journal-title":"Curr Oncol Rep"},{"key":"412_CR21","volume-title":"CNS as an HIV Reservoir","author":"R Swanstrom","year":"2016","unstructured":"Swanstrom R. CNS as an HIV Reservoir. Boston: CROI; 2016."},{"issue":"10","key":"412_CR22","doi-asserted-by":"publisher","first-page":"e1002286","DOI":"10.1371\/journal.ppat.1002286","volume":"7","author":"G Schnell","year":"2011","unstructured":"Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog. 2011;7(10):e1002286. https:\/\/doi.org\/10.1371\/journal.ppat.1002286 .","journal-title":"PLoS Pathog"},{"issue":"6","key":"412_CR23","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/cid\/civ417","volume":"61","author":"Cheuk Yan William Tong","year":"2015","unstructured":"Tong CY, Costelloe S, Hubb J, Mullen J, O\u2019Shea S, Marta M, et al. Deep sequencing of HIV-1 in cerebrospinal fluid. Clin. Infect. Dis. 2015;61(6):1022\u20135. https:\/\/doi.org\/10.1093\/cid\/civ417 .","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"412_CR24","doi-asserted-by":"publisher","first-page":"vew020","DOI":"10.1093\/ve\/vew020","volume":"2","author":"S Gianella","year":"2016","unstructured":"Gianella S, Kosakovsky Pond SL, Oliveira MF, Scheffler K, Strain MC, De la Torre A, et al. Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy. Virus Evolution. 2016;2(2):vew020. https:\/\/doi.org\/10.1093\/ve\/vew020 .","journal-title":"Virus Evolution"},{"issue":"10","key":"412_CR25","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/infdis\/jit805","volume":"209","author":"V Dahl","year":"2014","unstructured":"Dahl V, Gisslen M, Hagberg L, Peterson J, Shao W, Spudich S, et al. An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy. J Infect Dis. 2014;209(10):1618\u201322. https:\/\/doi.org\/10.1093\/infdis\/jit805 .","journal-title":"J Infect Dis"},{"issue":"12","key":"412_CR26","doi-asserted-by":"publisher","first-page":"e1003094","DOI":"10.1371\/journal.ppat.1003094","volume":"8","author":"CB Sturdevant","year":"2012","unstructured":"Sturdevant CB, Dow A, Jabara CB, Joseph SB, Schnell G, Takamune N, et al. Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children. PLoS Pathog. 2012;8(12):e1003094. https:\/\/doi.org\/10.1371\/journal.ppat.1003094 .","journal-title":"PLoS Pathog"},{"issue":"2","key":"412_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s11904-015-0267-7","volume":"12","author":"F Ferretti","year":"2015","unstructured":"Ferretti F, Gisslen M, Cinque P, Price RW. Cerebrospinal fluid HIV escape from antiretroviral therapy. Curr HIV\/AIDS Rep. 2015;12(2):280\u20138. https:\/\/doi.org\/10.1007\/s11904-015-0267-7 .","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"412_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.410420503","volume":"42","author":"RJ Ellis","year":"1997","unstructured":"Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol. 1997;42(5):679\u201388. https:\/\/doi.org\/10.1002\/ana.410420503 .","journal-title":"Ann Neurol"},{"issue":"10","key":"412_CR29","doi-asserted-by":"publisher","first-page":"e0139510","DOI":"10.1371\/journal.pone.0139510","volume":"10","author":"MF de Oliveira","year":"2015","unstructured":"de Oliveira MF, Gianella S, Letendre S, Scheffler K, Kosakovsky Pond SL, Smith DM, et al. Comparative analysis of cell-associated HIV DNA levels in cerebrospinal fluid and peripheral blood by droplet digital PCR. PLoS One. 2015;10(10):e0139510. https:\/\/doi.org\/10.1371\/journal.pone.0139510 .","journal-title":"PLoS One"},{"issue":"3","key":"412_CR30","doi-asserted-by":"publisher","first-page":"e1004720","DOI":"10.1371\/journal.ppat.1004720","volume":"11","author":"CB Sturdevant","year":"2015","unstructured":"Sturdevant CB, Joseph SB, Schnell G, Price RW, Swanstrom R, Spudich S. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog. 2015;11(3):e1004720. https:\/\/doi.org\/10.1371\/journal.ppat.1004720 .","journal-title":"PLoS Pathog"},{"issue":"5","key":"412_CR31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/650538","volume":"50","author":"Ana Canestri","year":"2010","unstructured":"Canestri A, Lescure FX, Jaureguiberry S, Moulignier A, Amiel C, Marcelin AG, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin. Infect. Dis. 2010;50(5):773\u20138. https:\/\/doi.org\/10.1086\/650538 .","journal-title":"Clinical Infectious Diseases"},{"issue":"14","key":"412_CR32","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","volume":"26","author":"MJ Peluso","year":"2012","unstructured":"Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012;26(14):1765\u201374. https:\/\/doi.org\/10.1097\/QAD.0b013e328355e6b2 .","journal-title":"AIDS"},{"issue":"6","key":"412_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/hiv.12243","volume":"16","author":"JM Tiraboschi","year":"2015","unstructured":"Tiraboschi JM, Munoz-Moreno JA, Puertas MC, Alonso-Villaverde C, Prats A, Ferrer E, et al. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch. HIV medicine. 2015;16(6):388\u201392. https:\/\/doi.org\/10.1111\/hiv.12243 .","journal-title":"HIV medicine"},{"issue":"12","key":"412_CR34","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1086\/657342","volume":"202","author":"A Eden","year":"2010","unstructured":"Eden A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, et al. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis. 2010;202(12):1819\u201325. https:\/\/doi.org\/10.1086\/657342 .","journal-title":"J Infect Dis"},{"key":"412_CR35","doi-asserted-by":"crossref","unstructured":"Perez Valero I, Letendre S, Ellis RD, Deutsch R, Franklin D, Clifford D, Heaton R, McCutchan J, McArthur J, Morgello S, Gelman B, Collier A, Grant I. Prevalence and risk factors for HIV CSF Viral Escape: Results from the CHARTER and HNRP cohorts. Oral abstract O334: Journal of International AIDS Society. 2012;15(Supplement 4).","DOI":"10.7448\/IAS.15.6.18189"},{"issue":"3","key":"412_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jinf.2012.04.007","volume":"65","author":"T Rawson","year":"2012","unstructured":"Rawson T, Muir D, Mackie NE, Garvey LJ, Everitt A, Winston A. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting. J Inf Secur. 2012;65(3):239\u201345. https:\/\/doi.org\/10.1016\/j.jinf.2012.04.007 .","journal-title":"J Inf Secur"},{"issue":"7","key":"412_CR37","doi-asserted-by":"publisher","first-page":"e70201","DOI":"10.1371\/journal.pone.0070201","volume":"8","author":"JR Santos","year":"2013","unstructured":"Santos JR, Munoz-Moreno JA, Molto J, Prats A, Curran A, Domingo P, et al. Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir\/ritonavir: an exploratory study. PLoS One. 2013;8(7):e70201. https:\/\/doi.org\/10.1371\/journal.pone.0070201 .","journal-title":"PLoS One"},{"issue":"15","key":"412_CR38","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/QAD.0000000000000400","volume":"28","author":"V Dahl","year":"2014","unstructured":"Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS. 2014;28(15):2251\u20138. https:\/\/doi.org\/10.1097\/QAD.0000000000000400 .","journal-title":"AIDS"},{"issue":"11","key":"412_CR39","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","volume":"13","author":"S Nightingale","year":"2014","unstructured":"Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, et al. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014;13(11):1139\u201351. https:\/\/doi.org\/10.1016\/S1474-4422(14)70137-1 .","journal-title":"Lancet Neurol"},{"issue":"12","key":"412_CR40","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1093\/infdis\/jiw454","volume":"214","author":"A Eden","year":"2016","unstructured":"Eden A, Nilsson S, Hagberg L, Fuchs D, Zetterberg H, Svennerholm B, et al. Asymptomatic cerebrospinal fluid HIV-1 viral blips and viral escape during antiretroviral therapy: a longitudinal study. J Infect Dis. 2016;214(12):1822\u20135. https:\/\/doi.org\/10.1093\/infdis\/jiw454 .","journal-title":"J Infect Dis"},{"issue":"5","key":"412_CR41","doi-asserted-by":"publisher","first-page":"e64398","DOI":"10.1371\/journal.pone.0064398","volume":"8","author":"LA van Arnhem","year":"2013","unstructured":"van Arnhem LA, Bunders MJ, Scherpbier HJ, Majoie CB, Reneman L, Frinking O, et al. Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy. PLoS One. 2013;8(5):e64398. https:\/\/doi.org\/10.1371\/journal.pone.0064398 .","journal-title":"PLoS One"},{"issue":"4","key":"412_CR42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2055-6640(20)30879-7","volume":"2","author":"J Joseph","year":"2016","unstructured":"Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, et al. Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD. USA J Virus Erad. 2016;2(4):243\u201350.","journal-title":"USA J Virus Erad"},{"issue":"2","key":"412_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.molimm.2004.06.017","volume":"42","author":"B Wirleitner","year":"2005","unstructured":"Wirleitner B, Schroecksnadel K, Winkler C, Fuchs D. Neopterin in HIV-1 infection. Mol Immunol. 2005;42(2):183\u201394. https:\/\/doi.org\/10.1016\/j.molimm.2004.06.017 .","journal-title":"Mol Immunol"},{"issue":"2","key":"412_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/QAI.0b013e31815ace97","volume":"47","author":"A Yilmaz","year":"2008","unstructured":"Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslen M. Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. J Acquir Immune Defic Syndr. 2008;47(2):168\u201373. https:\/\/doi.org\/10.1097\/QAI.0b013e31815ace97 .","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"412_CR45","doi-asserted-by":"publisher","first-page":"e0157160","DOI":"10.1371\/journal.pone.0157160","volume":"11","author":"A Eden","year":"2016","unstructured":"Eden A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, et al. Increased intrathecal immune activation in virally suppressed HIV-1 infected patients with neurocognitive impairment. PLoS One. 2016;11(6):e0157160. https:\/\/doi.org\/10.1371\/journal.pone.0157160 .","journal-title":"PLoS One"},{"issue":"2","key":"412_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s13365-013-0150-5","volume":"19","author":"L Yuan","year":"2013","unstructured":"Yuan L, Qiao L, Wei F, Yin J, Liu L, Ji Y, et al. Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. J Neurovirol. 2013;19(2):144\u20139. https:\/\/doi.org\/10.1007\/s13365-013-0150-5 .","journal-title":"J Neurovirol"},{"issue":"2","key":"412_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/01.inf.0000109247.67480.7a","volume":"23","author":"C McCoig","year":"2004","unstructured":"McCoig C, Castrejon MM, Saavedra-Lozano J, Castano E, Baez C, Lanier ER, et al. Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(2):114\u20138. https:\/\/doi.org\/10.1097\/01.inf.0000109247.67480.7a .","journal-title":"Pediatr Infect Dis J"},{"key":"412_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","volume":"3","author":"M Gisslen","year":"2016","unstructured":"Gisslen M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, et al. Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine. 2016;3:135\u201340. https:\/\/doi.org\/10.1016\/j.ebiom.2015.11.036 .","journal-title":"EBioMedicine"},{"issue":"4","key":"412_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13365-015-0333-3","volume":"21","author":"JL McGuire","year":"2015","unstructured":"McGuire JL, Gill AJ, Douglas SD, Kolson DL, group CHA-RTER. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neuro-Oncol. 2015;21(4):439\u201348. https:\/\/doi.org\/10.1007\/s13365-015-0333-3 .","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"412_CR50","doi-asserted-by":"publisher","first-page":"e88591","DOI":"10.1371\/journal.pone.0088591","volume":"9","author":"J Jessen Krut","year":"2014","unstructured":"Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, et al. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One. 2014;9(2):e88591. https:\/\/doi.org\/10.1371\/journal.pone.0088591 .","journal-title":"PLoS One"},{"issue":"9","key":"412_CR51","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1097\/QAD.0b013e32836010bd","volume":"27","author":"TH Burdo","year":"2013","unstructured":"Burdo TH, Weiffenbach A, Woods SP, Letendre S, Ellis RJ, Williams KC. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS. 2013;27(9):1387\u201395. https:\/\/doi.org\/10.1097\/QAD.0b013e32836010bd .","journal-title":"AIDS"},{"issue":"3","key":"412_CR52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2055-6640(20)30501-X","volume":"1","author":"J Ananworanich","year":"2015","unstructured":"Ananworanich J, Kerr SJ, Jaimulwong T, Vibol U, Hansudewechakul R, Kosalaraksa P, et al. Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children. J Virus Erad. 2015;1(3):196\u2013202.","journal-title":"J Virus Erad"},{"issue":"3","key":"412_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/QAD.0000000000000072","volume":"28","author":"S Kapetanovic","year":"2014","unstructured":"Kapetanovic S, Griner R, Zeldow B, Nichols S, Leister E, Gelbard HA, et al. Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis. AIDS. 2014;28(3):355\u201364. https:\/\/doi.org\/10.1097\/QAD.0000000000000072 .","journal-title":"AIDS"},{"key":"412_CR54","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3851\/IMP3157","volume":"22","author":"AR Eckard","year":"2017","unstructured":"Eckard AR, Rosebush JC, O\u2019Riordan MA, Graves CC, Alexander A, Grover AK, et al. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation. Antivir Ther. 2017;22:669\u201380. https:\/\/doi.org\/10.3851\/IMP3157 .","journal-title":"Antivir Ther"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-018-0412-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-018-0412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-018-0412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T12:46:25Z","timestamp":1604839585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-018-0412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1007\/s11904-018-0412-1","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"29 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance With Ethical Standards"}},{"value":"Ann Chahroudi has received grant support from the NIH (R01 AI125064, R01 AI133706 and P01 AI131276).Thor A. Wagner has received grant support from the NIH (R01 Al118500).Deborah Persaud has received grant support from the NIH (R01 HD080474).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}